GB9812662D0 - Therapeutic use - Google Patents
Therapeutic useInfo
- Publication number
- GB9812662D0 GB9812662D0 GBGB9812662.6A GB9812662A GB9812662D0 GB 9812662 D0 GB9812662 D0 GB 9812662D0 GB 9812662 A GB9812662 A GB 9812662A GB 9812662 D0 GB9812662 D0 GB 9812662D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- therapeutic use
- therapeutic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 230000001225 therapeutic effect Effects 0.000 title 1
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9812662.6A GB9812662D0 (en) | 1998-06-11 | 1998-06-11 | Therapeutic use |
AU42795/99A AU4279599A (en) | 1998-06-11 | 1999-06-08 | Use of an nk-1 receptor antagonist for treating cognitive disorders |
EP99955426A EP1119358A1 (en) | 1998-06-11 | 1999-06-08 | Use of an nk-1 receptor antagonist for treating cognitive disorders |
CA002334606A CA2334606A1 (en) | 1998-06-11 | 1999-06-08 | Use of an nk-1 receptor antagonist for treating cognitive disorders |
PCT/GB1999/001818 WO1999064009A1 (en) | 1998-06-11 | 1999-06-08 | Use of an nk-1 receptor antagonist for treating cognitive disorders |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9812662.6A GB9812662D0 (en) | 1998-06-11 | 1998-06-11 | Therapeutic use |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9812662D0 true GB9812662D0 (en) | 1998-08-12 |
Family
ID=10833616
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9812662.6A Ceased GB9812662D0 (en) | 1998-06-11 | 1998-06-11 | Therapeutic use |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1119358A1 (en) |
AU (1) | AU4279599A (en) |
CA (1) | CA2334606A1 (en) |
GB (1) | GB9812662D0 (en) |
WO (1) | WO1999064009A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPQ514600A0 (en) * | 2000-01-18 | 2000-02-10 | James Cook University | Brain injury treatment |
GB0020721D0 (en) * | 2000-08-22 | 2000-10-11 | Merck Sharp & Dohme | Therapeutic agents |
WO2004017977A2 (en) | 2002-08-23 | 2004-03-04 | Eli Lilly And Company | 2- (phenoxymethyl)- and 2- (phenylthiomethyl)-morpholine derivatives for use as selective norepinephrine reuptake inhibitors |
GB0219687D0 (en) | 2002-08-23 | 2002-10-02 | Lilly Co Eli | Benzyl morpholine derivatives |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1082959A1 (en) * | 1991-09-20 | 2001-03-14 | Glaxo Group Limited | NK1 Antagonists for the treatment of depression |
US5719147A (en) * | 1992-06-29 | 1998-02-17 | Merck & Co., Inc. | Morpholine and thiomorpholine tachykinin receptor antagonists |
PL181214B1 (en) * | 1993-12-29 | 2001-06-29 | Merck Sharp & Dohme | Derivatives o substituted morpholine and their application as pharmaceutic agents |
WO1996024353A1 (en) * | 1995-02-10 | 1996-08-15 | Eli Lilly And Company | Methods of treating or preventing psychiatric disorders |
GB9505491D0 (en) * | 1995-03-18 | 1995-05-03 | Merck Sharp & Dohme | Therapeutic agents |
GB9505692D0 (en) * | 1995-03-21 | 1995-05-10 | Glaxo Group Ltd | Chemical compounds |
EA001574B1 (en) * | 1996-06-21 | 2001-06-25 | Мерк Шарп Энд Домэ Лимитед | Spiro-piperidine derivatives and their use as therapeutic agents. |
WO1998013369A1 (en) * | 1996-09-25 | 1998-04-02 | Merck Sharp & Dohme Limited | Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists |
GB9711114D0 (en) * | 1997-05-29 | 1997-07-23 | Merck Sharp & Dohme | Therapeutic agents |
WO1999007375A1 (en) * | 1997-08-04 | 1999-02-18 | Merck Sharp & Dohme Limited | Use of nk-1 receptor antagonists for treating aggressive behaviour disorders |
TW426667B (en) * | 1997-11-19 | 2001-03-21 | Pfizer | Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance P antagonists |
-
1998
- 1998-06-11 GB GBGB9812662.6A patent/GB9812662D0/en not_active Ceased
-
1999
- 1999-06-08 AU AU42795/99A patent/AU4279599A/en not_active Abandoned
- 1999-06-08 CA CA002334606A patent/CA2334606A1/en not_active Abandoned
- 1999-06-08 EP EP99955426A patent/EP1119358A1/en not_active Withdrawn
- 1999-06-08 WO PCT/GB1999/001818 patent/WO1999064009A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1999064009A1 (en) | 1999-12-16 |
AU4279599A (en) | 1999-12-30 |
EP1119358A1 (en) | 2001-08-01 |
CA2334606A1 (en) | 1999-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9820113D0 (en) | Therapeutic agents | |
GB9816263D0 (en) | Therapeutic agents | |
GB9806102D0 (en) | Therapeutic agents | |
GB9804885D0 (en) | Therapeutic combination | |
GB9808663D0 (en) | Therapeutic agents | |
GB9801234D0 (en) | Therapeutic agents | |
GB9813576D0 (en) | Therapeutic agents | |
GB9813006D0 (en) | Therapeutic agents | |
GB9801210D0 (en) | Therapeutic agents | |
AP9901436A0 (en) | Therapeutic agents | |
GB9801397D0 (en) | Therapeutic agents | |
GB9801202D0 (en) | Therapeutic agents | |
GB9810092D0 (en) | Therapeutic agents | |
GB9811879D0 (en) | Therapeutic agents | |
GB9819484D0 (en) | Therapeutic agents | |
GB9816897D0 (en) | Therapeutic use | |
GB9812662D0 (en) | Therapeutic use | |
GB9810920D0 (en) | Therapeutic use | |
GB9815317D0 (en) | Therapeutic agents | |
GB9805716D0 (en) | Therapeutic agents | |
GB9817838D0 (en) | Therapeutic agents | |
GB9821179D0 (en) | Therapeutic use | |
GB9811624D0 (en) | Therapeutic use | |
GB9816723D0 (en) | Therapeutic agents | |
GB9812664D0 (en) | Therapeutic use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |